Bristol-Myers Squibb (BMY) Application for Zeposia for Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by FDA

Go back to Bristol-Myers Squibb (BMY) Application for Zeposia for Treatment of Ulcerative Colitis Accepted for Filing with Priority Review by FDA
Bristol-Myers Squibb (NYSE: BMY) Delayed: 64.88 -0.16 (0.25%)
Previous Close $65.04    52 Week High $77.12 
Open $65.20    52 Week Low $49.03 
Day High $65.29    P/E 42.13 
Day Low $64.62    EPS $1.54 
Volume 7,555,202